plerixafor has been researched along with Cancer of Testis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carbone, A; De Blasio, A; Ortu La Barbera, E; Pacilli, M; Papa, A; Rossi, L; Salvatori, R; Tomao, S; Zaccarelli, E; Zappone, E | 1 |
| Avecilla, S; Cushing, M; Mark, T; Pagan, C; Rhodes, J; Shore, T; Storch, E; van Besien, K | 1 |
| Galonska, L; Haas, R; Klärner, V; Kobbe, G; Saure, C; Schroeder, T; Weigelt, C | 1 |
| Bogner, C; Bokemeyer, C; Fiedler, W; Frickhofen, N; Hübel, K; Isernhagen, J; Kilic, N; Kobold, S | 1 |
1 trial(s) available for plerixafor and Cancer of Testis
| Article | Year |
|---|---|
Plerixafor is effective and safe for stem cell mobilization in heavily pretreated germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Combined Modality Therapy; Compassionate Use Trials; Cyclams; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Heterocyclic Compounds; Humans; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Seminoma; Testicular Neoplasms; Ultrasonography; Young Adult | 2011 |
3 other study(ies) available for plerixafor and Cancer of Testis
| Article | Year |
|---|---|
Plerixafor and autologous stem cell transplantation: impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy.
Topics: Adult; Antineoplastic Agents; Benzylamines; Cyclams; Cyclophosphamide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Male; Neoplasms, Germ Cell and Embryonal; Receptors, CXCR4; Stem Cell Transplantation; Testicular Neoplasms | 2013 |
A novel hematopoietic progenitor cell mobilization and collection algorithm based on preemptive CD34 enumeration.
Topics: Adult; Aged; Algorithms; Antigens, CD34; Benzylamines; Blood Cell Count; Cell Separation; Clinical Protocols; Cyclams; Drug Synergism; Erythrocytes; Female; Flow Cytometry; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematologic Diseases; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Testicular Neoplasms; Time Factors; Transplantation, Autologous; Young Adult | 2015 |
Plerixafor enables successful hematopoietic stem cell collection in an extensively pretreated patient with testicular cancer.
Topics: Adult; Benzylamines; Cyclams; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Heterocyclic Compounds; Humans; Male; Receptors, CXCR4; Testicular Neoplasms; Treatment Outcome | 2010 |